Jurgen Reefschlager

Title: Jurgen Reefschlager: Innovator in Antiviral Pseudopeptides

Introduction

Jurgen Reefschlager is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of antiviral research, particularly through his innovative work on pseudopeptides. With a total of 3 patents, Reefschlager's inventions focus on developing effective antiviral agents.

Latest Patents

Reefschlager's latest patents include groundbreaking inventions such as "Pseudopeptides with antiviral activity." This invention relates to novel pseudopeptides characterized by a specific general formula, which are designed to combat cytomegaloviruses. Another significant patent is "Valine-containing pseudopeptides with antiviral activity," which also targets cytomegaloviruses and outlines processes for their preparation and use as antiviral agents.

Career Highlights

Jurgen Reefschlager is associated with Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. His work at Bayer has allowed him to focus on the development of antiviral therapies, contributing to advancements in medical science.

Collaborations

Throughout his career, Reefschlager has collaborated with esteemed colleagues such as Dieter Habich and Gert Streissle. These collaborations have fostered a productive environment for innovation and research in antiviral treatments.

Conclusion

Jurgen Reefschlager's contributions to the field of antiviral research through his patents on pseudopeptides highlight his role as a significant inventor. His work continues to pave the way for new antiviral therapies that can combat serious viral infections.